Kestra Medical Technologies, Ltd. (KMTS): R&D Expense

Annual figures by period end, from SEC filings.

$19.48M

Year ended 2026-04-30

$22.28M

Trailing 12 months to 2026-07-31

2024-04-30 R&D Expense (USD) 2026-04-30

Period ended	R&D Expense	Change YoY	Source filing
2026-04-30	$19.48M	+24.5%	2026-07-14, From 2025-05-01
2025-04-30	$15.65M	+1.0%	2026-07-14, From 2024-05-01
2024-04-30	$15.49M	n/a	2025-07-17, From 2023-05-01

R&D Expense at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	R&D Expense	Change YoY
Kestra Medical Technologies, Ltd. (KMTS)	2026-04-30	$19.48M	+24.5%
NeuroPace Inc (NPCE)	2025-12-31	$27.89M	+17.9%
Pulmonx Corp (LUNG)	2025-12-31	$19.49M	+10.9%
Beta Bionics, Inc. (BBNX)	2025-12-31	$34.79M	+32.9%
Delcath Systems, Inc. (DCTH)	2025-12-31	$29.25M	+110.8%
Iradimed Corp (IRMD)	2025-12-31	$2.98M	+5.0%
TELA Bio, Inc. (TELA)	2025-12-31	$9.22M	+4.6%
Anika Therapeutics, Inc. (ANIK)	2025-12-31	$25.77M	+0.9%
Orasure Technologies Inc (OSUR)	2025-12-31	$42.53M	+63.3%

Compare KMTS, NPCE, LUNG, BBNX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗